Dr. Robert Scott Fisher, MD

Dr. Fisher practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Fisher's NPI, 1669425740, was assigned on May 18, 2006. Dr. Fisher graduated from Stanford University School Of Medicine in 1977. Dr. Fisher's California license number on file is G37260.

Dr. Fisher's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Fisher's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Fisher is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Fisher to 1 more hospital, named with a free account. Dr. Fisher's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fisher practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Fisher's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Fisher is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fisher's licenses on file in 3 states: California, Arizona and Maryland.

Dmand AI lists epilepsy, parkinson's disease and seizures among the conditions Dr. Fisher treats.

CMS data shows 163 Medicare services from Dr. Fisher across 5 procedure codes in 2024, for 155 Medicare patients. Medicare paid $23,744 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Fisher in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fisher's median patient age at 41, with 56% women.

In 2024, Dr. Fisher wrote 420 Medicare Part D claims for 37 patients. 74% of them were for generic drugs. CMS names the drug for 336 of them, across 19 drugs with 11 or more claims each, at $137,812 in total drug cost. In 2023, CMS named 176 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fisher for performance year 2024, reported as part of a group. Dr. Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fisher as offering telehealth.

Dmand AI links 202 papers to Dr. Fisher, published from 2001 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Epilepsy, Electroencephalography and Seizures. Dr. Fisher has published most often in Epilepsia. Dr. Fisher's most frequent co-authors are David Allan Prince, MD, Mark S. Wallace, MD and Matthew Q. Bromer, DO.

Dmand AI links Dr. Fisher to 5 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Epilepsy, Brain Diseases and Epilepsies, Partial. Stanford University sponsors the most, 2.

CMS Open Payments shows 73 general payments to Dr. Fisher from 10 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 69% of the total. Medtronic USA, Inc. paid the most, $42,031.

Dmand AI lists 1 award for Dr. Fisher, most recently CMS Stage 1 EHR in 2013.

Dr. Fisher graduated from Stanford University School Of Medicine in 1977.

Dr. Fisher is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.